Worked as a co-investigator in a randomized, double blind, controlled trial of new drug (immunocin) in Chronic Obstructive Pulmonary Disease (COPD) and bronchiectasis patients, regulated under good clinical practice guidelines.
Worked as co-investigator in randomized, double blind controlled trial of immuno modulator drug (immumod) in Tuberculosis.
Worked as co-investigator in randomized, double blind controlled trial of antioxidant drug (Carofit) in Tuberculosis.
Worked as co-investigator in randomized, double blind controlled international trial of Inhaled Insulin (Elle Lily) in diabetic patients in KEM hospital, Mumbai.
Worked as co-investigator in randomized, double blind controlled trial of Rifabutin in sputum positive Tuberculosis when working as lecturer in Sion Municipal Hospital.
Study of Efficacy of Immunomodulator Immunocin, as a Add-on therapy, in the Management of patients with Chronic Obstructivve Pulmonary Disorder and Bronchiectasis- published in the journal The Indian Practitioner June 2002; Vol. 55: 393-399.
As a Lecturer had compiled a book â€œZonal Workshop for establishment of Revised National Tuberculosis Control Program in Medical Colleges- West Zone April 2003 under the auspices of World Health Organization & Central TB Divisionâ€ which was published in August 2003.
Did a poster presentation â€œRespiratory problems in HIV Positive patientsâ€ at HIV/AIDS Conference held at Hotel Rennaissance in January 2003.
Member, Association of Medical Consultants (AMC) , Mumbai.
Member, Indian Association of Bronchology (IAB)
Member, American College of Chest Physicians (ACCP)
Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Kuntal Pal and his staff know how they are doing and how they can improve their services.
How was your experience with Dr. Kuntal Pal?
Help other patients, and let the doctor know how he's doing